Insider · CIK 0001623532

Manor Moshe

Reports to the SEC for 1 company · CARMIEL, L3

Transactions

Companies

Filings

CIK

0001623532

Forms 4 and 5

Insider transactions

3 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-09-13	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director, President & CEO	AAward	+1.3M sh	—	—	1,300,000
2017-05-16	PLXProtalix BioTherapeutics, Inc.P Purchase	Director, President & CEO	PPurchase	+50K sh	$0.81	+$40.5K	50,000
2014-09-29	PLXProtalix BioTherapeutics, Inc. · Stock Options (Right to Buy)A Award	Director, President & CEO	AAward	+900K sh	—	—	900,000

C/O PROTALIX BIOTHERAPEUTICS, INC. 2 SNUNIT STREET, SCIENCE PARK, #455

CARMIEL, L3, 20100